Setmelanotide

Setmelanotide (RM-493) is a selective melanocortin 4 receptor (MC4R) agonist with EC50s of 0.27 nM and 0.28 nM for human and rat MC4R, respectively.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Setmelanotide(CAS 920014-72-8)

CAT No: HB00098

CAS No:920014-72-8

Synonyms/Alias:Setmelanotide;920014-72-8;RM-493;BIM-22493;Setmelanotida;Setmelanotide acetate;UNII-N7T15V1FUY;N7T15V1FUY;(4R,7S,10S,13R,16S,19R,22R)-22-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carboxamide;1504602-49-6;L-Cysteinamide, N2-acetyl-L-arginyl-L-cysteinyl-D-alanyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-, cyclic (2->8)-disulfide;Setmelanotide [USAN:INN];Setmelanotidum;Setmelanotide [USAN];Setmelanotide (RM-493);SETMELANOTIDE [INN];SETMELANOTIDE [WHO-DD];GTPL9272;CHEMBL3301624;SCHEMBL21840385;DTXSID501032320;EX-A5542;BDBM50581319;AT23144;CS-6399;DB11700;IRC-022493;DA-67236;DA-77812;HY-19870;Q21098917;RM-493; BIM-22493; IRC-022493;N2-acetyl-L-arginyl-L-cysteinyl-D-alanyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-cysteinamide, cyclic (2-8)-disulfide;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C49H68N18O9S2
M.W/Mr.
1117.3
Sequence
One Letter Code:RCAHFRWC
Three Letter Code:Ac-Arg-Cys(1)-D-Ala-His-D-Phe-Arg-Trp-Cys(1)-NH2

Setmelanotide is a synthetic peptide and selective agonist of the melanocortin-4 receptor (MC4R), recognized for its unique role in modulating energy homeostasis and appetite regulation. Structurally designed to mimic endogenous melanocortin peptides, Setmelanotide exhibits high receptor specificity, which enables precise targeting of neuronal pathways involved in metabolic control. Its molecular configuration allows for enhanced stability and bioactivity compared to naturally occurring analogs, making it a valuable research tool in the study of metabolic signaling. The compound's activity is primarily mediated through the central nervous system, where it influences key neuropeptides and signaling cascades that govern food intake and energy expenditure. Researchers value Setmelanotide for its ability to dissect the underlying mechanisms of metabolic disorders and for its contribution to the broader understanding of neuroendocrine regulation.

Obesity Research: In the field of obesity research, Setmelanotide has become an indispensable molecule for investigating the genetic and molecular causes of severe obesity, particularly those forms associated with rare genetic mutations affecting the MC4R pathway. By activating the melanocortin-4 receptor, it enables scientists to delineate the functional consequences of receptor deficiencies and to explore compensatory pathways that may contribute to excessive weight gain. The peptide's selective action helps clarify the interplay between central appetite signals and peripheral metabolic cues, providing a clearer picture of how disruptions in these systems can lead to pathological weight accumulation.

Appetite Regulation Studies: For studies focused on appetite regulation, MC4R agonists such as Setmelanotide are utilized to probe the central mechanisms that govern hunger and satiety. By modulating neuronal circuits in the hypothalamus, the compound allows researchers to map the neurochemical events that trigger feeding behavior and to identify downstream effectors involved in the sensation of fullness. The insights gained from these investigations are essential for developing new strategies to address dysregulated eating patterns and for understanding the neurobiological basis of appetite control.

Energy Homeostasis Mechanisms: Investigation into energy homeostasis greatly benefits from the use of Setmelanotide, as it provides a powerful means to study how the brain integrates signals related to energy stores and nutrient availability. The compound's receptor-specific activation facilitates the examination of feedback loops between central melanocortin pathways and peripheral metabolic processes, such as glucose and lipid metabolism. This research direction is crucial for unraveling the factors that maintain energy balance and for identifying potential points of intervention in metabolic diseases.

Neuroendocrine Pathway Elucidation: Setmelanotide serves as a critical probe in the elucidation of neuroendocrine pathways that coordinate physiological responses to metabolic demands. By selectively engaging MC4R, it helps researchers trace the hormonal and neuronal circuits involved in stress responses, thermogenesis, and adaptive changes to energy intake. These studies expand the understanding of how neuroendocrine systems adapt to both internal and external stimuli, and they highlight the intricate network of signals that maintain homeostasis.

Pharmacological Screening and Drug Discovery: In the context of pharmacological screening, Setmelanotide is widely used as a reference compound for evaluating the efficacy and selectivity of novel MC4R-targeted molecules. Its well-characterized mode of action provides a benchmark for the development of next-generation peptide therapeutics designed to modulate metabolic pathways. Through comparative analyses, researchers can assess the potency, receptor affinity, and downstream effects of candidate compounds, accelerating the identification of promising leads for further investigation in metabolic research.

Peptide-based Mechanistic Studies: Extensive use of Setmelanotide in peptide-based mechanistic studies has advanced the understanding of signal transduction processes within the melanocortin system. By serving as a tool to dissect receptor-ligand interactions, it aids in mapping the structural determinants of MC4R activation and in identifying key residues critical for receptor function. These mechanistic insights are invaluable for the rational design of new peptides with improved pharmacological properties and for deepening the scientific community's knowledge of GPCR-mediated signaling in metabolic regulation.

Shipping Condition
Room temperature in continental US; may vary elsewhere.
InChI
InChI=1S/C49H68N18O9S2/c1-26-41(70)63-37(20-30-22-55-25-59-30)46(75)64-35(18-28-10-4-3-5-11-28)44(73)62-34(15-9-17-57-49(53)54)43(72)65-36(19-29-21-58-32-13-7-6-12-31(29)32)45(74)66-38(40(50)69)23-77-78-24-39(47(76)60-26)67-42(71)33(61-27(2)68)14-8-16-56-48(51)52/h3-7,10-13,21-22,25-26,33-39,58H,8-9,14-20,23-24H2,1-2H3,(H2,50,69)(H,55,59)(H,60,76)(H,61,68)(H,62,73)(H,63,70)(H,64,75)(H,65,72)(H,66,74)(H,67,71)(H4,51,52,56)(H4,53,54,57)/t26-,33+,34+,35-,36+,37+,38+,39+/m1/s1
InChI Key
HDHDTKMUACZDAA-PHNIDTBTSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide Synthesis ServicescGMP Peptide ServicePeptide CDMOEpitope Mapping ServicesPeptide Nucleic Acids SynthesisPeptide Modification ServicesPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers